2022년 국내 카바페넴내성장내세균속균종(CRE) 감염증의 신고 현황-Reference-Cited by-同舟云学术

2022년 국내 카바페넴내성장내세균속균종(CRE) 감염증의 신고 현황

Published:2023-11-28 Issue:4 Volume:17 Page:115-127
ISSN:2005-811X
Container-title:Public Health Weekly Report
language:en
Short-container-title:Public Health Weekly Report

Author:

임 지현¹,심 주영²,이 현주²,현 정희²,이 승재²,박 숙경²

Affiliation:

1. 질병관리청 호남권질병대응센터 제주출장소

2. 질병관리청 의료안전예방국 의료감염관리과

Publisher

Korea Disease Control and Prevention Agency (Public Health Weekly Report)

Link

https://pdf.medrang.co.kr/PHWR/2024/017/PHWR017-04-115.pdf

Reference14 articles.

1. Carbapenem Resistance: A Review

2. Korea Disease Control and Prevention Agency (KDCA). 2023 Guidelines for control of healthcare-associated infection. KDCA; 2023.

3. Joo S, Kim M, Shin E, Kim J, Yoo J. Molecular characteristic analysis and antimicrobial resistance of carbapenem-resistant Enterobacteriaceae (CRE) isolates in the Republic of Korea, 2017-2020. Public Health Wkly Rep 2021;14:3790-804.

4. Kim MK, Joo S, Shin E, Kim J, Yoo J. Antimicrobial resistance and molecular characteristics of carbapenem-resistant Enterobacteriaceae isolated in the Republic of Korea, 2021. Public Health Wkly Rep 2023;16:541-59.

5. Outbreaks of Carbapenem Resistant Enterobacterales (CRE) According to the Type of Hospitals

Cited by 2 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Antimicrobial Use and Carbapenem-Resistant Enterobacterales in Korea: A Nationwide Case-Control Study With Propensity Score Matching;Journal of Korean Medical Science;2024

2. Guidelines for Antibacterial Treatment of Carbapenem-Resistant Enterobacterales Infections;Infection & Chemotherapy;2024